Agencies and Commissions August 17, 2009 – Federal Register Recent Federal Regulation Documents
Results 1 - 23 of 23
Notice of Public Information Collections Being Submitted for Review to the Office of Management and Budget, Comments Requested
The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act of 1995, 44 U.S.C. 3501-3520. An agency may not conduct or sponsor a collection of information unless it displays a currently valid control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the Paperwork Reduction Act (PRA) that does not display a valid control number. Comments are requested concerning (a) whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility; (b) the accuracy of the Commission's burden estimate; (c) ways to enhance the quality, utility, and clarity of the information collected; and (d) ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology.
Notice of Availability of a Statement of Policy: Testing of Component Parts With Respect to Section 108 of the Consumer Product Safety Improvement Act
The Consumer Product Safety Commission (``Commission'') is announcing the availability of a document titled, ``Statement of Policy: Testing of Component Parts With Respect to Section 108 of the Consumer Product Safety Improvement Act'' (``Statement of Policy''). Section 108 of the Consumer Product Safety Improvement Act of 2008 (``CPSIA'') prohibits the sale of certain products containing specified phthalates. The Statement of Policy establishes the Commission's position with respect to testing products to determine whether they contain phthalates in excess of the statutory limits.
License Renewal Interim Staff Guidance LR-ISG-2007-01: License Renewal Interim Staff Guidance Process, Revision 1; Notice of Availability
The NRC is issuing the final License Renewal Interim Staff Guidance (LR-ISG) LR-ISG-2007-01, ``License Renewal Interim Staff Guidance Process, Revision 1'' (revised LR-ISG process). This process describes the basic framework for developing and implementing interim changes to certain NRC license renewal guidance documents. These documents facilitate the implementation of and NRC staff review of license renewal applications submitted in accordance with Title 10 of the Code of Federal Regulations (10 CFR), Part 54, ``Requirements for Renewal of Operating Licenses for Nuclear Power Plants,'' and Part 51, ``Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions'' of 10 CFR. The revised LR-ISG process supersedes the existing process issued on December 12, 2003, entitled, ``Process for Interim Staff Guidance.'' An electronic copy of the revised LR-ISG process is available in the NRC's Agencywide Documents Access and Management System (ADAMS) under Accession No. ML091950069.
North Dakota Disaster Number ND-00016
This is an amendment of the Presidential declaration of a major disaster for the State of North Dakota (FEMA1829DR), dated 04/10/2009.
Nebraska Disaster Number NE-00027
This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of Nebraska (FEMA-1853-DR), dated 07/31/2009.
Disaster Declaration #11694 and #11695; North Dakota Disaster Number ND-00015
This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of North Dakota (FEMA-1829-DR), dated 03/24/2009.
Notice of Intent To Grant Partially Exclusive License
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license worldwide to practice the invention described and claimed in U.S. Patent No. 7,094,045, entitled``Microencapsulation System and Method'', U.S. Patent No. 7,295,309, entitled ``Microparticle Analysis System and Method'' to NuVue Therapeutics, Inc. (formerly known as Critical Care Innovations, Inc.), having its principal place of business in Fairfax, Virginia. The fields of use are for both clinical and veterinary applications in the production and applications of microcapsules and microencapsulation of all cyto-toxic anti-cancer drugs. Also included are externally- triggered microcapsules including the use of ultrasound and magnetic flux triggering technologies, in situ activation inside microcapsules, cell encapsulation, and urokinase and DNA measurement of metastasis for diagnostic testing. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
Global Plus 1 Contracts
The Commission is making changes to the Competitive Product List, including adding a Global Plus 1 contract. This is consistent with changes in a recent law governing postal operations. Republication of the lists of market dominant and competitive products is also consistent with requirements in the new law.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
